Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) FCF Payout Ratio: 2017-2025

Historic FCF Payout Ratio for Fortress Biotech (FBIO) over the last 7 years, with Sep 2025 value amounting to -0.03.

  • Fortress Biotech's FCF Payout Ratio was N/A to -0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.04, marking a year-over-year change of. This contributed to the annual value of -0.05 for FY2024, which is 20.01% up from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's FCF Payout Ratio is -0.03, which was down 351.06% from -0.01 recorded in Q2 2025.
  • Fortress Biotech's FCF Payout Ratio's 5-year high stood at -0.00 during Q3 2022, with a 5-year trough of -0.09 in Q1 2021.
  • Its 3-year average for FCF Payout Ratio is -0.04, with a median of -0.03 in 2025.
  • Per our database at Business Quant, Fortress Biotech's FCF Payout Ratio skyrocketed by 93.86% in 2021 and then plummeted by 1,456.05% in 2024.
  • Fortress Biotech's FCF Payout Ratio (Quarterly) stood at -0.05 in 2021, then climbed by 15.23% to -0.04 in 2022, then tumbled by 37.17% to -0.06 in 2023, then tumbled by 1,456.05% to -0.09 in 2024, then skyrocketed by 93.03% to -0.03 in 2025.
  • Its last three reported values are -0.03 in Q3 2025, -0.01 for Q2 2025, and -0.01 during Q1 2025.